09:00-9:10
|
Àλ縻
|
ÀÌÁØÇü(ȸÀå)
|
Recent Update of management of patient with thyroid cancer
ÁÂÀå: ±èÀº°æ(¼¼ºê¶õ½ºº´¿ø), ±èÁöÈÆ(¼¿ï´ëÇб³º´¿ø)
|
09:10-09:40
|
The Revised 2016 Korean Thyroid Association Guidelines for Thyroid Nodules and Cancers:
Differences from the 2015 American Thyroid Association Guidelines.
|
ÀÌÀº°æ (±¹¸³¾Ï¼¾ÅÍ ³»°ú)
|
09:40-10:10
|
Current Paradigm Shift in Thyroid Surgery
|
¹ÚÁø¿ì (ÃæºÏ´ëº´¿ø ¿Ü°ú)
|
10:10-10:40
|
Active surveillance of PTMC
|
±èÅ¿ë (¼¿ï¾Æ»êº´¿ø ³»°ú)
|
10:40-11:00
|
ÈÞ½Ä
|
|
Recent Update of Radiologic diagnosis and management in patient with thyroid cancer
ÁÂÀå: ÀÌÈ£±Ô(Á¦ÁÖ´ëÇб³º´¿ø), ÀÌ¿µÈç(°í´ë¾È»êº´¿ø)
|
11:00-11:25
|
Future guideline for selecting FNA at a thyroid nodule: Confusion over
|
°ûÁø¿µ (¼¼ºê¶õ½ºº´¿ø)
|
11:25-11:50
|
Core needle biopsy of the thyroid: 2016 Consensus Statement and Recommendations from KSThR
|
±è¿©±º (ºÐ´ç¼¿ï´ëº´¿ø)
|
11:50-12:15
|
Invitation to AJCC 8th edition: Staging of thyroid cancer
|
¹ÚÁöÀ± (¼¿ï¾Æ»êº´¿ø)
|
2017 ´ëÇÑ°©»ó¼±¿µ»óÀÇÇÐȸ : What’s going on?
ÁÂÀå: ÀÌÁØÇü(µ¿¾Æ´ëº´¿ø), ¹éÁ¤È¯(¼¿ï¾Æ»êº´¿ø)
|
13:30-13:40
|
ÇÐȸÀÇ »êÇÏÇÐȸ Â÷º°¿¡ ´ëÇÑ Á¦µµÀû °³¼±: ÇöȲ°ú ÇâÈÄ °èȹ
|
¼ºÁø¿ë (´ë¸²¼º¸ðº´¿ø)
|
13:40-13:50
|
°©¿µÈ¸ Áø·áÁöħ °³¹ß: ±× °á°ú¿Í Àü¸Á
|
³ªµ¿±Ô (°¸ª¾Æ»êº´¿ø)
|
13:50-14:00
|
°©»ó¼± ÃÊÀ½ÆÄ ±Þ¿©ÈÀÇ °æ°ú¿Í ÇâÈÄ °úÁ¦
|
½ÉÁ¤¼® (À§µå½ÉÀÇ¿ø)
|
14:00-14:10
|
°©»ó¼± ¿µ»óÀÇÇÐȸ ¿Ü·¡ Ŭ¸®´Ð: ÇöȲ°ú ¹®Á¦Á¡
|
ÀÓÇö°æ (¼¿ï¼øõÇ⺴¿ø)
|
14:10-14:20
|
Current status of publication: KSThR-KJR-Ultrasonography-Relationship
|
±è¼öÁø (´º°í·Áº´¿ø)
|
14:20-14:30
|
°©¿µÈ¸ Áöȸ ÇöȲ°ú È°¼ºÈ ¹æ¾È
|
Á¤¼Ò·É (¼¿ï¼º¸ðº´¿ø)
|
14:30-15:00
|
Åä·Ð
|
|
15:00-15:20
|
ÈÞ½Ä
|
|
Special Focus in radiology & thyroid radiology
ÁÂÀå: ³ªµ¿±Ô(°¸ª¾Æ»êº´¿ø), ¹é¼±¹Ì(ÇØ¿î´ë³ª´®°úÇູº´¿ø)
|
15:20-15:50
|
ÀǷ῵»ó°ú ÀΰøÁö´ÉÀÇ µ¿Çâ
|
ÃÖÇö¼® (¼¿ï¼º¸ðº´¿ø)
|
15:50-16:20
|
Current status and Future perspective of TIRADS and CAD
|
¹éÁ¤È¯ (¼¿ï¾Æ»êº´¿ø)
|
16:20-16:50
|
Image-guided ablation of PTMC (RFA, laser and MWA)
|
±èÁöÈÆ (¼¿ï´ëÇб³º´¿ø)
|